• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Low rates found for chlamydia testing, retesting in young women

Article

Although the Centers for Disease Control and Prevention recommends annual chlamydia screening for sexually active women aged 25 years and younger, data from 2006 to 2008 show that only 30% of those aged 15 to 19 years reported having had a chlamydia test within the past year.

Although the Centers for Disease Control and Prevention (CDC) recommends annual chlamydia screening for sexually active women aged 25 years and younger, data from 2006 to 2008 show that only 30% of those aged 15 to 19 years reported having had a chlamydia test within the past year.

The infection rate among women aged 15 to 19 years was 3,378.2 cases per 100,000 in 2010, a 1.9% increase from 2009. Although women aged 20 to 25 years had a slightly higher infection rate (3,407.9 cases/100,000), the survey found that 42% of them reported being tested within the past year.

The chlamydia infection rate among girls aged 10 to 14 years was much lower than the older patient group in 2010 (131.9/100,000) but represented a 3.26% increase from 2009.

Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2010. Atlanta, GA: US Department of Health and Human Services; 2011.

Related Videos
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Scott Ceresnak, MD
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
© 2024 MJH Life Sciences

All rights reserved.